Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
Earnings for Mirati Therapeutics (MRTX)
Earnings in 2023 (TTM): -$0.77 B
According to Mirati Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.77 B. In 2022 the company made an earning of -$0.76 B a decrease over its 2021 earnings that were of -$0.58 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Mirati Therapeutics from 2008 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.77 B | 0.7% |
| 2022 | -$0.76 B | 32.52% |
| 2021 | -$0.58 B | 55.18% |
| 2020 | -$0.37 B | 66.3% |
| 2019 | -$0.23 B | 116.42% |
| 2018 | -$0.11 B | 43.47% |
| 2017 | -$71.54 M | -14.62% |
| 2016 | -$83.78 M | 29.46% |
| 2015 | -$64.72 M | 66.91% |
| 2014 | -$38.78 M | 25.28% |
| 2013 | -$30.95 M | 54.43% |
| 2012 | -$20.05 M | |
| 2010 | -$14.59 M | -30.54% |
| 2009 | -$21.01 M | 164.92% |
| 2008 | -$7.93 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | $0.18 B | -124.25% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -$2.17 M | -99.72% | Bahamas |